ArticleCureus2026
Multifocal Autoimmune Pancreatitis Mimicking Pancreatic Neoplasm in a Young Adult: A Diagnostic Challenge.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Autoimmune pancreatitis (AIP) is an uncommon fibroinflammatory pancreatic disorder that may closely mimic pancreatic malignancy, particularly when presenting with focal or multifocal mass-like lesions. Prompt recognition is essential to prevent unnecessary invasive procedures, inappropriate oncological management, and to allow timely initiation of glucocorticoid therapy. We report the case of a 32-year-old call center employee with a history of asthma who presented with a three-week history of progressive epigastric pain radiating to the back. Notably, he had no clinical or biochemical evidence of obstructive jaundice, with a total bilirubin level of 0.24 mg/dL at presentation. Initial abdominal CT demonstrated multifocal poorly defined hypovascular pancreatic lesions associated with pancreatic enlargement, raising concern for a pancreatic neoplasm. Laboratory evaluation revealed preserved hepatic function, normal serum calcium and triglyceride concentrations, mild inflammatory response, elevated total immunoglobulin G (IgG) (1673 mg/dL), mildly elevated IgG4 (153.5 mg/dL), and positive antinuclear antibodies. Tumour markers were negative. Subsequent MRI showed multifocal enlargement involving the pancreatic head, body, and tail, with delayed homogeneous enhancement, preservation of the main pancreatic duct calibre, and peripheral capsule-like features. These findings strongly suggested autoimmune pancreatitis. Histological confirmation was not initially obtained because corticosteroid therapy had already been initiated following multidisciplinary evaluation. The patient demonstrated rapid clinical improvement and remained asymptomatic during corticosteroid tapering. Endoscopic ultrasound-guided tissue acquisition and urgent imaging reassessment were planned to consolidate diagnostic certainty and exclude alternative diagnoses. This case highlights the diagnostic complexity of autoimmune pancreatitis presenting as multifocal pancreatic masses and illustrates the challenges associated with initiating corticosteroid therapy before histological confirmation. Recognition of characteristic radiological patterns and integration of clinical and serological findings remain crucial to avoid unnecessary invasive or surgical interventions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.